𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bilateral subthalamic nucleus stimulation in a parkinsonian patient with previous unilateral pallidotomy and thalamotomy

✍ Scribed by Elena Moro; Rianne A. J. Esselink; Nadège Van Blercom; Elena Caputo; Pierre Pollak; Patricia Limousin; Marwan I. Hariz

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
86 KB
Volume
15
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subthalamic deep brain stimulation in pa
Subthalamic deep brain stimulation in patients with a previous pallidotomy
✍ William G. Ondo; Yavuz Silay; Mike Almaguer; Joseph Jankovic 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

The safety and efficacy of subthalamic nucleus (STN) deep brain stimulation (DBS) in patients who have had a previous unilateral pallidotomy is not clear. We identified 10 patients (9 male) at the Baylor College of Medicine Parkinson's Disease Center who underwent STN DBS after prior unilateral pall

Bilateral subthalamic nucleus deep brain
Bilateral subthalamic nucleus deep brain stimulation in a patient with cervical dystonia and essential tremor
✍ Kelvin L. Chou; Howard I. Hurtig; Jurg L. Jaggi; Gordon H. Baltuch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract The role of subthalamic nucleus (STN) deep brain stimulation (DBS) is well established in Parkinson's disease, but experience with STN DBS in other movement disorders is limited. We report on a patient with medically refractory cervical dystonia and essential tremor resulting in dystoni

Effects of bilateral stimulation of the
Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations
✍ Karen Østergaard; Niels Sunde; Erik Dupont 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

We present the efficacy and side effects of bilateral deep brain stimulation (DBS) of the subthalamic nuclei (STN) performed with a more simplified surgical procedure than described by the Grenoble group. A consecutive series of 26 patients with advanced and levodopa-responsive Parkinson's disease a